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ABSTRACT 
Ionizing radiation is a major therapy for cancer. Damage to the endothelium and 
upregulation of inflammatory responses are major side effects of radiotherapy, but the 
mechanisms behind these processes are not clear. A key component of the inflammatory 
response is leukocytes adhesion to the endothelium in a multi-step process involving 
leukocyte tethering to the endothelium, followed by rolling, firm adhesion/spreading and 
extravasation. Adhesion molecules mediate this process, particularly, E-selectin and 
ICAM-1, which are inducible adhesion molecules.  E-selectin is involved in the initial 
tethering and rolling steps of the adhesion cascade while ICAM-1 appears to be involved 
in the latter steps.  We have hypothesized that in response to irradiation, the endothelium 
becomes activated, increases its expression of adhesion molecules such as E-selectin and 
ICAM-1, and supports the increased interaction of leukocytes with the endothelium. To 
probe this hypothesis, we have investigated the expression of E-selectin and ICAM-1 on 
Human umbilical vein endothelial cells (HUVEC), human microvascular endothelial cells 
(HDMECs) and transformed microvascular endothelial cells (HMEC-1) at 5 hr, 24 hr, 48 
hr and 72 hr post-irradiation. We have also developed an in vitro flow model to study the 
functional consequences of the  radiation induced upregulation of   adhesion molecules, 
primarily E-selectin  and  ICAM-1. Endothelial cells were grown in 35mm dishes and 
irradiated with a single dose of 10 Gy. HL60 (human  promyelocytic leukemia) cells 
were perfused over the irradiated (IR) endothelial cells in a parallel plate flow chamber at 
shear stress of 0.5-2.0 dynes/cm2. Flow cytometry analysis  at 5 hr, 24hr, 48 hr and 72 hr 
post-irradiation showed upregulation of E-selectin at 5 hr post-IR only on HDMECs. 
ICAM-1 was upregulated at 24 hr (HDMECs), and 48 hr (HUVECs and HMEC-1).  
 vi 
Flow assays revealed an increase in the rolling and adhesion of HL60 cells on 5 hr post-
IR HDMEC. No rolling was observed on HUVECs and HMEC-1 monolayers 5 hr post-
IR consistent with the absence of E-selectin from the flow cytometry data. Semi-static 
assays at 48 hr post-IR on HUVECs showed an increase in the number of adherent cells.  
There was a radiation dose dependent (5 Gy vs. 10 Gy) increase in the expression of 
adhesion molecules, which was significant at 72 hr post-IR. Our findings suggest that 
irradiation selectively impacts the functional aspects of the inflammatory response. 
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Chapter 1. INTRODUCTION & LITERATURE REVIEW 
 Cancer is the second leading cause of the death in prosperous countries around the world. 
In the United States 1 out of every 4 deaths is attributed to cancer.  This year about 563,100 
Americans are predicted to die of cancer (2). Additionally, about 1,221,800 people are expected 
to be diagnosed with cancer (2). With the major advancements in the field of surgical therapy, 
hormonal therapy, radiotherapy and chemotherapy most cancers can be cured if detected early. 
Cancer is a collective term for a group of diseases, which can be classically defined as an 
uncontrolled growth, and spread of abnormal cells”. If the spread is not controlled, it can result 
in death.  
The origin of the word cancer is credited to the Greek physician Hippocrates (460-370 
B.C.), considered the "Father of Medicine." Hippocrates used the terms "carcinos" and 
"carcinoma" to describe non-ulcer forming and ulcer-forming tumors. In Greek these words refer 
to a crab, and hence most applicable to this disease because the finger like spreading projections 
from a cancerous mass suggest the shape of a crab. The oldest recorded reference to cancer 
(although the term cancer was not used) was in Egypt and dates back to approximately 1600 B.C. 
In most cases tumor cells in a tumor are clones of single precursor cell (76).  A tumor can 
be classified as benign (has not invaded neighboring tissue) or malignant (has invaded 
neighboring tissue). All tumors, benign and malignant, consist of proliferating cells that 
constitute the parenchyma, and supportive stroma made up of connective tissue and blood 
vessels.  Tumors grow in an exponential phase (Figure1-1). It takes more time for a tumor to 
grow from a non-detectable size to a size that can be clinically detectable (1 to 10g) than to grow 
to a size that can kill the person (1 to10kg). In many cases the cancerous cells in a tumor are 
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dead or are in the process of dying. Small numbers of cells, however, continue to grow and these 
are the cells, which make the clinical treatment necessary.  
 
 
Figure 1-1. Hypothetical growth curve for a human tumor, showing the long     
latent period prior to detection. From Tannock. (76) 
 
The microenvironment of a tumor is drastically different from that of normal cells.  
Tumor vasculature has very few smooth muscle cells (sometimes none). Endothelial cells are 
very irregular (recently a cancer has been discovered where no endothelial cells are present (7)).                       
(years) 
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The basement membrane is missing; vessels are tortuous with arteriovenous shunts and 
no defined hierarchy. The vascular oxygen supply to tumors is poorer than that of normal cells. 
The diffusion of O2 is limited to 70-150 µm, which is responsible for the hypoxic region in the 
tumors (76). Tumors also possess high interstitial pressure, have low pH and low pO2.   
Tumors also differ from the normal cells in their biochemical (19) and genetic (17) 
makeup.  In most tumors, chromosomal abnormalities can be seen. It takes on average five to 
seven mutations to transform a normal cell into a cancer cell. In our body, a spontaneous 
mutation occurs at a frequency of 10 -6 to 10-7 per cell per generation. However, exposure to 
mutagens can increase the frequency by 10 to 100 folds. These mutagenesis can be due to viral 
carcinogenesis (26,28), chemical carcinogenesis (58), radiation carcinogenesis (29), and 
chromosomal aberrations of the oncogenes (12,17,80). 
The consequence of chromosomal aberrations influences the function of two distinct 
classes of genes in human tumors: dominantly acting genes and tumor suppressor genes (80). 
When an oncogene becomes inappropriately activated, it signals the cells to proliferate, thus 
leading to the formation of a tumor. This is known as a dominantly acting gene.  The body also 
has genes known as tumor suppressor genes that when functioning normally inhibit cell 
proliferation. Loss or inactivation of these genes can result in cell proliferation, eventually 
leading to a tumor. 
The probability of developing a tumor increases exponentially with age (Figure1-2). 
Once a tumor starts to grow rapidly in the body, the physicians have three primary options to get 
rid of the tumor: surgical removal, treatment with chemotherapy or treatment with ionizing 
radiation. Ionizing radiation is the second most common mode of treatment following surgery.  
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 Figure 1-2. Relationship between age and cancer incidence.  From Tannock (76). 
 
Ionizing Radiation 
X-rays were discovered in the year 1895 by German physicist Wilhelm Conrad 
Roentgen. Parallel to this was the discovery of radioactivity in 1898 by Becquerel, which laid the 
foundation for gamma rays. The first famous biological experiments, which laid the foundation 
for clinical radiation therapy, were performed in 1920s and 1930s in Paris, where testes of rams 
were irradiated with x-rays. It proved to be impossible to sterilize the animals in a single dose 
without a severe reaction to the skin of the scrotum. However, on fractionating the total dose 
over a period of time, sterilization could be achieved with minimal skin damage. The basis for 
this phenomenon was that the testis is a model for a rapidly growing tumor, while the skin 
represented the normal tissue response to radiation damage. Both x-rays and gamma rays 
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constitute part of the continuos spectrum of electromagnetic radiation.   All types of radiation can 
be considered as moving packets (quanta) of energy called photons. When absorbed by the 
medium through which they pass, both x-rays and gamma rays give up energy to produce fast 
moving electrons by the Compton, photoelectric effect or the pair production processes (44). X-
rays are produced extranuclearly while gamma rays are produced intranuclearly, but they do not 
differ in nature or properties. Both eventually cause damage in the same manner with the release 
of localized high energy. The raising of an electron in an atom or molecule to a higher energy 
level without the actual ejection of that electron is called excitation. If the radiation has sufficient 
energy to eject one or more orbital electrons from the atom or molecule, the process is known as 
ionization and the radiation is called ionization radiation.  
 The important characteristic of ionizing radiation is to locally release large amount of 
energy. The energy dissipated is more than enough to break strong chemical bonds. Most of the 
energy absorbed produces ions and reactive radicals that interact with biochemical processes in 
the body, making them shift towards the apoptotic pathway. It has been estimated that 
approximately 1 x 105 ionization’s can occur within the cell per gray of radiation dose absorbed, 
that can lead to approximately 200 single stranded and 25 to 50 double stranded breaks in the 
DNA which trigger apoptosis (76).  Radiation damages both tumors and normal tissue, but in 
general tumors are more susceptible to radiation damage. At low or fractionated doses of 
radiation, most of the damaged tissues can repair themselves. Those tissues that cannot do so 
either go into the apoptotic process or develop in an irregular manner leading to the late side 
effects. Thus, radiation can cause either temporary or permanent loss of function in normal 
tissues. Figure 1-3 shows the survival curves for some normal tissues in mice. 
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             Figure 1-3.  Survival curves for some normal tissues. From Tannock (76) 
    
The energy range most commonly used in clinical therapy is 6MeV to 20 MeV. The 
radiation dose is measured in terms of amount of energy (joules) absorbed per unit mass (kg) and 
is quoted in grays (1J/kg).  The role of radiation therapy is to maximize tumor kill and minimize 
normal tissue damage and this aspect forms the basis for the dose limitation during radiotherapy.  
 
Side Effects of Radiation Therapy 
Patients receiving radiation therapy are at risk of developing complications due to 
radiation damage of normal tissues. These effects can be divided into early or acute responses, 
which occur within days to weeks of treatment, and late effects, which may take months to 
develop. Acute responses occur primarily on tissues that divide rapidly such as the cells of the 
skin, intestine, etc. Late effects tend to happen in tissues where the cells divide either slowly 
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(e.g., cells of liver or kidney, endothelial cells) or not at all (e.g., central nervous system or 
muscle).  
Radiation has been found to increase the permeability of vessels (13). Radiation causes 
both structural and functional changes in the vasculature (5), which may lead to fibrosis (61). In 
a number of normal tissues upregulation of cytokines (IL family, TGF-β, TNF-α, PDGF) 
following ionizing radiation has been shown (6,18,49,68). These observations suggest that 
cytokines may contribute to the pathological conditions arising at later time points post-
irradiation. One interesting feature that is pertinent to this study is the increased leukocyte-
endothelial interactions following radiation mediated by adhesion molecules. Before this post 
radiation phenomenon is discussed we will review the leukocyte adhesion cascade.  
  
Leukocyte Adhesion Cascade 
Leukocytes are in a common sense the bodyguards of our body protecting us from 
bacteria, viruses and other pathogens. Most of this defense mechanism occurs at the tissue level 
when leukocytes migrate to the site of infection/damage and overcome the pathogen. In this 
process however, the normal tissue is also damaged which in time repairs itself. After activation, 
the first step in this pathway is the leukocyte adhering to the endothelium. This leukocyte 
adhesion to the endothelium is an important aspect of many physiological and 
pathophysiological processes (15, 45, 73,74). It has been shown that the leukocyte adhesion to 
the endothelium is a multistep process (51).  
After upregulation of adhesion molecules on endothelial cells, circulating leukocytes 
interact with the vessel wall and slow down their velocity initiating a phenomenon called rolling 
characterized by the ability of leukocytes to roll on the endothelium. Leukocytes then firmly 
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adhere to the endothelium and start to extravasate into the tissues by migrating through the 
endothelium (Figure 1-4).  These processes of leukocyte-endothelium interactions are mediated 
by a series of receptor ligand interactions present on the endothelium and the leukocytes.  
Figure 1-4. Neutrophil adhesion cascade. 
 
Very rarely does one see the leukocytes rolling, adhering and extravasating on normal 
endothelium. Usually, the adhesion cascade depends on the activation of the endothelium. 
Activation of the endothelium increases the expression of certain adhesion molecules. These 
adhesion molecules mediate the interaction of the leukocytes by interacting with their counter 
ligands on the leukocytes. Primarily the adhesion molecules upregulated on the endothelium are 
E-selectin, ICAM-1 and VCAM-1 (9). The endothelium can be activated in several ways (55). A 
typical time course followed by the molecules after activation by IL-1 is depicted in Figure 1-5.  
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 Figure 1-5. Time course followed by three prominent adhesion 
molecules. From Bevilacqua et al. (9) 
 
Leukocytes are activated upon coming in contact with the endothelium. This activation is 
characterized by a conformational change of the β2 intergrin from a non-active form to an active 
form (23). This conformational change makes the leukocytes more adhesive to their counter 
receptors ICAM-1 (23) expressed by the endothelial cells. These conformation changes were 
detected by the use of monoclonal antibodies (23). The adhesion molecules involved in the 
adhesion cascade are described in detail in the following section. 
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Adhesion Molecules 
Adhesion molecules, which play a major role in the leukocyte-endothelial interactions, 
belong to the families of Selectins, Immunoglobulin and Integrins. 
 
Selectins:  
Selectins are known to be responsible for mediating the attachment and rolling of 
leukocytes onto the endothelium (1, 50,52).  The selectins have a structure characterized by an 
amino terminus (Ca2+ -dependent lectin-like domain), an epidermal growth factor (EGF) like 
domain, a variable number of consensus repeats similar to those appearing in complement-
regulatory proteins, a transmembrane domain and a cytoplasmic tail (9). There are three types of 
Selectin: E, P and L-selectin. A generalized schematic of their structures is shown in Figure 1-6. 
 
Figure 1-6. Schematic of the selectins. From Bevilacqua et al. (9) 
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E-Selectin: 
A member of the Selectin family, E-Selectin (CD62E) is a 107 - 115 kDa cell surface 
glycoprotein. E-selectin is an inducible adhesion molecule and is upregulated following 
activation by IL-1, TNF-α and LPS (10,11). E-selectin expression requires de novo protein 
synthesis (10,11). Previous studies show that E-selectin mediates leukocyte attachment and 
rolling under flow conditions (1,52). The counter ligands for E-selectin present on the leukocytes 
are P-selectin glycoprotein ligand-1 (34, 59), a 106 kDa protein commonly called as PSGL-1 and 
L-Selectin (64,65) present on almost all types of leukocytes. Structural study of these ligands has 
shown that all of them share a common glycan the SLex type. SLex has been found to mediate 
adhesion of leukocytes to E-selectin (14,57). 
 
P-Selectin: 
 Human P-Selectin (CD62P) is a cell surface glycoprotein expressed by activated 
platelets and endothelial cells. P-Selectin is translocated to the cell surface within minutes 
following stimulation. P-selectin can mediate the attachment and rolling of leukocytes to the 
endothelium (51,54,59). The primary ligand for P-Selectin is PSGL-1 (59). PSGL-1 is found 
universally on almost all the types of leukocytes and is located on the microvilli (59). 
 
L-Selectin: 
 Human L-Selectin (CD62L) is a cell surface glycoprotein expressed constitutively on a 
variety of leukocytes. Two forms of L-Selectin have been reported, apparently arising as a result 
of post-translational modifications. The lymphocyte form shows an apparent molecular weight of 
74 kDa, while the neutrophil form is 90-100 kDa and the monocytes form is 110kDa. L-selectin 
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is constitutively expressed on a variety of leukocytes and is localized on the microvilli tips (65). 
L-selectin is shed from activated leukocytes (45). The ligands for L-selectin are sgp50, sgp90 
(CD34), GlyCAM-1, MadCAM-1 and E-selectin. L-selectin has been implicated in playing a 
role in the attachment and rolling of leukocytes to E-selectin under flow (52,64). 
 
Immunoglobulins (IgG) family: 
 All the member of this immunoglobulin family (IgG family) have an immunoglobulin 
like domain (79). The domain consists of 90-100 amino acids arranged in two sheets of anti-
parallel β strands and stabilized by disulfide bonds (79). The molecules involved in the adhesion 
cascade are Intercellular Adhesion Molecules (ICAM-1 and ICAM-2) and Vascular Cellular 
Adhesion Molecule (VCAM-1). These molecules play a major role in the firm adhesion and 
extravasations of leukocytes (55,73). Both ICAM-1 and ICAM-2 are constitutively expressed on 
the endothelial cells (15). However, ICAM-2 is not modulated by cytokines (15). The primary 
ligand for ICAM-2 has been found to be β2 integrin (15). 
 VCAM-1 is upregulated by cytokines and is a ligand of LFA-1 and Mac-1 (21). VCAM-1 
levels are elevated at 24 hr and return to base line by 48 hr. The corresponding ligands for 
VCAM-1 are β1 integrin, VLA-4 (α4β1) and α4β7 (73). 
ICAM-1 is constitutively expressed on endothelial cells, epithelial cells, lymphocytes and 
fibroblasts (56). ICAM-1 is expressed constitutively at low levels on endothelial cells (9).  Upon 
activation of the endothelium, the expression of ICAM-1 increases significantly (9). ICAM-1 
levels reach peak values by 24 hr and remain high for several days (9). The ligands for ICAM-1 
are β2 integrins, LFA-1 and Mac-1 (9). 
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Integrins: 
 Integrins are involved in several physiological processes integral to the normal 
functioning of the body (69). They also are important players in the adhesion cascade of the 
leukocytes. Integrins have three main structural motifs; a α subunit I-domain, 7 NH2-terminal 
repeats and a β subunit –I domain (53). The α subunit I-domain has a dinucleotide binding fold 
and a β sheet surrounded by α helices (53).  
 The subunits, α and β are related both in terms of structure and function (53). The 
integrins differ mostly in the make-up of the β chain (22). This chain helps in distinguishing 
between different integrins. The β2 subunit has several features including: a 769 amino acid 
sequence with an integral membrane protein, an extracellular domain with six N-glycosylation 
sites, a transmembrane domain and a cytoplasmic domain (46). β2  is the integrin that plays a 
dominant role in the interaction of leukocytes to the endothelium. They are also called 
leukocyte integrins as they are only expressed on leukocytes (72). β2 integrin include LFA-1 
(CD11a/CD18), Mac-1 (CD11b/CD18), p150, 95 (CD11c/CD18) and the latest addition in the 
group is αD/β2 (77). Both LFA-1 and Mac-1 are the major players in the adhesion cascade (46). 
 LFA-1 is a heterodimer protein made up of a α1 chain and a β2 chain (56). Mac-1 is a 
heterodimer consisting of αm chain and β2 chain. Mac-1 plays a similar role as that of LFA-1 in 
the adhesion cascade by binding to ICAM-1.  ICAM-1 and ICAM-2 are ligands for LFA-1. The 
ligand for Mac-1 is ICAM-1 (24,25) and E-selectin has been suggested to interact with Mac-1 
(3,48). Schematic view of the integrins and the IgG superfamily adhesion molecules is 
summarized in Figure 1-7.  
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Figure 1-7. Integrins and IgG superfamily molecules. From Bevilacqua et al. (9) 
 
Without the interactions of these adhesion molecules, the leukocyte adhesion cascade 
cannot function. In summary, the selectins (E, P and L) mediate the leukocyte rolling on the 
endothelium in interactions with PSGL-1. Firm adhesion is then mediated by the Integrins (β2) 
and the IgG family (ICAM-1, ICAM-2). Figure 1-8 summarizes the leukocyte adhesion 
cascade. 
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Figure 1-8. Adhesion molecules in the adhesion cascade. 
 
Upregulation of Adhesion Molecules Following Irradiation 
There has been increased interest in the upregulation of adhesion molecules following 
radiation during the last decade.  Investigators have shown the upregulation of adhesion 
molecules, primarily E-selectin (35,36,37,41,42) and ICAM-1 (4,30,31,38,39,42) following 
irradiation of human endothelial cells. Hallahan et al. reported that E-selectin is upregulated as 
early as 2 hr, post-irradiation (IR) reaching a peak in 6 hrs and returns to baseline by 24 hrs 
(35,36) on human umbilical vein endothelial cells (HUVECs). Heckmann et al. reported that the 
mRNA levels of E-selectin and ICAM-1 are upregulated significantly at 24 hr post-irradiation 
(42) on human dermal microvascular endothelial cells. ICAM-1 is found to be upregulated at 16 
hr post-irradiation reaching peak values at 24 hrs and remains elevated until 48 hrs (36) on 
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HUVECs from the data of Hallahan et al. In contrast to this result, Gaugler et al. also working on 
HUVECs observed the presence of ICAM-1, and not E-selectin, post-irradiation (31). ICAM-1 
was upregulated at 48 hr post-IR and the levels remained high as long as 10 days post-IR (31).  
In vivo studies on the expression of adhesion molecules by Hallahan et al. have shown the 
presence of both E-selectin and ICAM-1 in the lungs of mice following irradiation (39). ICAM-1 
mRNA has also been reported to be upregulated in human skin cultures (4,8), and dermal 
endothelial cells (42) following irradiation. 
Recently P-selectin has been found to be accumulated in the lumen of tumor blood 
vessels following radiation (40).  Use of monoclonal antibodies to P-selectin and ICAM-1 in a 
rat model showed decrease in the number of rolling and firmly adhering leukocytes (63) after 
irradiation. Although upregulation of adhesion molecules in response to radiation have been 
reported, the functional consequence of the presence of E-selectin and ICAM-1 following 
irradiation has not been studied. Secondly, there have been controversial results regarding the 
expression of adhesion molecules based on the cell type (microvascular vs. large vessels) and 
radiation source (x-ray vs. gamma radiation).   
In the current study, we investigated the functional consequences of the upregulation of 
the adhesion molecules after irradiation using an in vitro flow chamber. Endothelial cells from 
microvessels and large vessels irradiated with x-ray or gamma were compared for the expression 
of adhesion molecules. HL60 cells, which have become a standard substitute for leukocytes in 
experiments were used to quantify leukocyte-endothelium interactions following radiation 
damage under conditions of flow. 
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Chapter 2. OBJECTIVES 
Ionizing radiation is a major treatment therapy for the treatment of cancer.  Damage to 
the endothelium and inflammatory responses are the major side effects of radiotherapy, but the 
mechanisms behind these processes are not clear.  Over the last decade, much has been learned 
about the inflammatory process in general.  Consideration of these findings can give insight into 
the cellular and molecular mechanisms, which may govern tissue damage in response to 
irradiation. 
 
Specific Aims 
The main objective of the research presented here was to quantify the expression of 
adhesion molecules on the endothelium following ionizing radiation and to determine functional 
significance of the upregulation of these molecules in an in vitro flow chamber model. 
 
Hypothesis 
We hypothesize that exposure to ionizing radiation during radiotherapy activates the 
normal endothelium, which leads to the increase in expression of adhesion molecules such as E-
selectin and ICAM-1, and supports the increased interaction of leukocytes and endothelial cells. 
This increased interaction leads to leukocytes extravasating into the tissues and mediating 
damage. Understanding of the functional interactions between the molecules can lead to 
reduction in the damage to the normal tissue. 
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Key Questions 
 
1. What adhesion molecules are upregulated on the endothelial cells following exposure to 
ionizing radiation?  
2. Is the upregulation of adhesion molecules radiation dose dependent ? 
3. What is the functional significance of the upregulation of these molecules in the 
interaction of leukocytes and the endothelium? 
4. Do endothelial cells from different parts of the body react differently to ionizing 
radiation? 
5. What is the effect of shear stress on the interaction of the leukocytes with the radiation 
activated endothelium? 
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Chapter 3. MATERIALS AND METHODS 
            The methods described herein were used to quantify the expression of adhesion 
molecules on the irradiated endothelium and the functional consequence of their interactions 
with leukocytes.  An in vitro flow chamber was developed to model the in vivo blood flow 
conditions.  
 
Experimental Design 
Three different types of endothelial cell cultures were used to study the expression of 
adhesion molecules following ionizing radiation. The endothelial cell cultures were human 
umbilical vein endothelial cells (HUVECs), human dermal microvascular endothelial cells 
(HDMECs) and HMEC-1 which is the transformed immortalized progeny of HDMECs. All the 
experiments were conducted at the following passages of the endothelial cells; HUVECs (P3-
P6), HDMECs (P4-P7) and HMEC-1 (P21-P26). 
The endothelial cells were irradiated with a single dose of 10Gy (x-ray or gamma-
radiation). It has been shown that a dose of 5Gy or 10Gy produces observable changes in the 
normal tissue microvasculature (5). Irradiated HUVECs and HMEC-1 were observed at 5 hr, 
24hr, 48 hr and 72 hr post-IR for the expression of adhesion molecules. HDMECs were analyzed 
at 5 hr, 24 hr and 48 hr post-IR. Non-irradiated cells served as negative controls and IL-1β 
activated endothelial cells served as positive controls for the expression of adhesion molecules.  
The experimental design is shown schematically in Figure 3-1.  
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Figure 3-1. Experimental design of the study. 
 
To study the functional interactions, human promyelocytic leukemia cells (HL60), which 
have become a standard for use as substitutes of leukocytes were utilized in an in vitro flow 
chamber to model the in vivo flow conditions.  In vitro flow chambers provide the flexibility and 
Endothelial cells Non-Irradiated 
Control 
Irradiated 10 Gy 
 
IL-1β activated 
(5U/ml) 
5 hr Post-irradiation 
24 hr Post-irradiation 
48 hr Post-irradiation 
72 hr Post-irradiation 
5 hr  Control  
24 hr Control 
48 hr Control 
 72  hr Control 
5 hr IL-1 beta 
24 hr IL-1 beta 
48 hr IL-1 beta 
72 hr IL-1 beta 
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control to vary the shear stress by varying the flow rates in order to understand the 
pathophysiological consequences following radiation.  
 
Media 
M199, RPMI-1640, Fetal bovine serum (FBS), L-glutamine, penicillin/streptomycin 
solution, EDTA-Trypsin solution, Trypsin neutralizing solution,  and Dulbeco phosphate buffer 
solution (DPBS) was obtained from Biowhittaker, Walkersville, MD. MCDB131 was purchased 
from Life Technologies, Rockville, MD. Endothelial growth factor was bought from Biomedical 
Technologies, Boston, MA. Gelatin, heparin, dibutyryl cyclic AMP, Formaldehyde and 
hydrocortisone were obtained from Sigma Chemical, St. Louis, MO. Bovine serum albumin was 
obtained from Fisher Scientific, Pittsburgh, PA. 
 
Antibodies and Cytokines 
 IL-1β was obtained from Calbiochem, La Jolla, CA. Antibodies to E-selectin, ICAM-1 
and IgG1 were obtained from R & D systems, Minneapolis, MN. Anti-mouse IgG, Heavy and 
Light Chain(Goat) F (ab’)2 fragment conjugated to FITC was purchased from Caltag 
Laboratories, CA. Antibodies to LFA-1, PSGL-1, Slex, β2 integrin and Mac-1 were  kind gifts of 
Dr. Douglas Goetz of University of Memphis, TN. 
 
Endothelial Cell Cultures 
Human umbilical vein endothelial cells (HUVECs) were obtained from Birthing Center, 
Strong Memorial Hospital, Rochester, NY). Human microvascular endothelial cells (HDMECs) 
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and transformed human microvascular endothelial cells (HMEC-1) were obtained from Dr. 
Robert Swerlick, Emory University, Atlanta, GA.   
Human umbilical cord veins were utilized as a source of endothelial cells (HUVEC) 
utilizing the methods of Gimbrone et al. (33)and Wagner et al. (78) as modified by Sporn et al. 
(71).  A sterile technique was employed in all manipulations of the cord.  The cord was severed 
from the placenta soon after birth, placed in a sterile container and held at 4°C until processing.  
Storage time did not exceed 48 hours.  The cells were allowed to grow for 72-96 hours and were 
then passaged in T25 cm2 culture flasks pre-coated with 0.2% gelatin for use in our studies.  All 
umbilical cords used were considered normal by the obstetrical staff (Birthing Center, Strong 
Memorial Hospital, Rochester, NY). Cells were maintained in M199 with 10 % FBS, 2mM L-
glutamine supplemented with 100µg/ml of heparin, 50µg/ml of endothelial growth factor and 
100U/ml penicillin/streptomycin on 0.2 % gelatin coated tissue culture dishes at 37° in 5% CO2. 
Confluent cells were trypsinized and  subcultured at a ratio of 1:3. All the studies were 
conducted on passage 3-6 of these cells. 
Transformed microvascular endothelial cells were maintained in MCDB131 with10 % 
FBS, 2mM L-glutamine and 100U/ml penicillin/streptomycin solution on 0.2 % gelatin coated 
tissue culture dishes at 37° in 5% CO2. Confluent cells were trypsinized and  subcultured at a 
ratio of 1:3. Cells used in our studies were from passage 22-26. 
Primary microvascular endothelial cells were isolated from human neonatal foreskins as 
described previously (75) and were obtained from the laboratories of Dr. Robert Swerlick at the 
Emory University. Culture medium was MCDB131 with 10% human serum (Irvine Scientific), 
10% FBS,  2mM L-glutamine, 5 x10-4 M dibutyryl cyclic AMP, 1 µg/ml hydrocortisone acetate 
and 100 U/ml of penicillin/streptomycin. The cells were grown on 0.2 % gelatin coated tissue 
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culture dishes at 37° in 5% CO2. Confluent cells were trypsinized and  subcultured at a ratio of 
1:3. Cells used in our studies were from passage 4-7. 
 
HL60 Cells 
HL60 (human promyelocytic leukemia cells)  were obtained from American Type Cell 
Culture (ATCC, Manassas, VA). The frozen cells were thawed at 37 °C and placed in RMPI-
1640 media supplemented with 10% FBS, 2mM L-glutamine and 100 U/ml of 
penicillin/streptomycin in a T75 cm2 flask. The flask was incubated at 37°C in 5% CO2. HL60 
cells grow in suspensions. Upon reaching confluence, the cell suspension was further diluted to 
allow for more cell growth. 
 
Irradiation 
Prior to irradiation, confluent endothelial cells in T25 cm2 flasks were replenished  with 
fresh media. HDMECs  media was replaced with media lacking cyclic AMP (cyclic AMP has 
been found to suppress expression of E-selectin (60,66).  Cells were irradiated with a single dose 
of  radiation (10 Gy (X-ray or gamma)). The x-ray dose rate was 2 Gy/min using a Siemens 
Primus (4000 series) linear accelerator (6MV) and the collimator diameter used was 5 cm. The 
dose calculations and calibrations were performed by Dr. Waleed Gaber (Research Investigator 
at the St. Jude Children’s Hospital, Memphis, TN). The gamma radiation was delivered from 
Mark I, cesium source irradiator (Veterans Affair Hospital, Memphis, TN) at a dose rate of 4.2 
Gy per minute. Cells taken to the radiation facility but not irradiated served as negative controls. 
IL-1 β  (10 U/ml) activated cells served as positive controls to show the presence of the adhesion 
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molecules. Post-irradiation cells were incubated at 37°C for 5hr, 24hr, 48 hr and 72 hr to be 
analyzed for the expression of adhesion molecules.  
For the in vitro flow assay, endothelial cells were grown in 35 mm dishes. Confluent cells 
were irradiated and incubated  until the experimental time points. Non-irradiated cells served as 
negative controls and IL-1β activated cells served as positive controls. 
 
Flow Cytometry 
Flow cytometric analysis was carried out to test for the presence of adhesion molecules.  
At the respective time points post-IR (5 hr, 24 hr, 48 hr and 72 hr), cells were trypsinized with 
0.01% EDTA-trypsin mixture in the presence of 1 % BSA.  Cells were washed in phosphate 
buffer saline and incubated with antibodies to E-selectin, ICAM-1 or murine IgG1 at a 
concentration of 20µg/ml for 30 minutes at 4°C.  Cells were washed and incubated with 
secondary antibody (Anti-mouse IgG, Heavy and Light Chain(Goat) F (ab’)2 fragment 
conjugated to FITC for further 30 minutes at 4°C (1:50 neat dilution of antibody). Cells were 
washed and fixed in 2% formaldehyde to be analyzed using flow cytometry (Epics - Profile II 
Beckman Coulter Inc., Fullerton, CA). 
Flow cytometric analysis was also carried on the HL60 cells  to check for the expression 
of ligands of the adhesion molecules E-selectin and  ICAM-1; namely, Slex, PSGL-1, LFA-1, 
Mac-1, and the β2 integrin chain. In brief, HL60 cell suspension was placed in a 50 ml centrifuge 
tube and was centrifuged at 12,000 rpm for 5 minutes at 37°C.  The cells were washed in RPMI 
–1640 media containing 5% FBS and resuspended to 1 x 106 cells/ml. One ml of the suspension 
was aliquoted into 1.5 ml centrifuge tubes. The cells were spun down and 40µl of antibody 
(20µg/ml) diluted in RPMI-1640 was added against Slex, PSGL-1, LFA-1, Mac-1, and the β2 
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integrin chain and incubated at 4°C for 30 minutes. The cells were washed and incubated for 
further 30 minutes at 4°C with secondary antibody (Anti-mouse IgG, Heavy and Light Chain 
(Goat) F (ab’)2 fragment ) conjugated to FITC at 1:50 neat dilution. The cells were washed with 
RMPI-1640  and then fixed in 2% DPBS to be analyzed in a flow cytometer (Epics - Profile II 
Beckman Coulter Inc., Fullerton, CA). 
 
In Vitro Flow Chamber Assay 
To probe the functional consequence of the presence of adhesion molecules on the 
irradiated endothelium a flow assay was used. The flow chamber was obtained from Glycotech 
(Rockville, MD). A schematic of the flow chamber is shown in Figure 3-2. 
.  
Figure 3-2. Schematic of the flow chamber. 
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The irradiated cells on the 35 mm dish were washed  with the HL60 cells media (RPM1 –
1640 with 10% FBS and 100 U/ml of Penicillin/Streptomycin) and the flow chamber was placed 
over it. A  gasket of approximate thickness 250 µm was placed between  the culture dish and the 
flow chamber (the exact thickness of the gasket was obtained with the use of the z axis scale on 
the microscope). The flow path width was 0.5 cm. The flow chamber was placed over an 
inverted microscope (Nikon, Japan-TE300 series) and viewed at 10x Phase1. HL60 cells (105 
cells/ml) suspended in RPM1-1640 media were perfused over the endothelial cells at shear stress 
values of 0.5 –2.0 dynes/cm2 by varying the flow rate with a syringe pump (Harvard Apparatus, 
Boston, MA). These shear stress are values are typically observed in the post-capillary venules in 
vivo (70).  
The  flow rate needed to develop the desired shear stress  was calculated using the 
equation for the shear stress at the wall in a parallel plate flow chamber: 
γ =  3µQ ,                               (1) 
           2h2 w 
where γ=  shear stress in dynes/cm2 
                        µ = viscosity of the medium (0.76cP in our experiments) 
                      Q= flow rate of the medium containing HL60 cells (ml/min) 
             h= thickness of the gasket (height of the chamber) in cm 
             w = flow path width (0.5 cm) 
 
The derivation for equation 1 has been shown previously (70). Experiments were 
recorded with a video camera (Dage-MTI, Inc, USA). The number of rolling, and adherent cells 
were counted for a period of 3 minutes. The camera was connected to a video monitor 
(Panasonic Model No. WV-5410) and the images were recorder on SVHS videotapes  on a video 
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recorder (JVC SVHS Model No. HR-54900U) for offline analysis. A video title maker 
(Videonics Title Maker 3000, Mexico) was used to place an electronic time and stamp 
(containing experimental  date, radiation status, lens used and the shear stress) on each video 
field. The experimental set up is shown in Figure 3-3. 
                      Figure 3-3. Experimental setup of the flow chamber assay. 
 
A semi-static flow assay was used at 48hr post-irradiation to investigate the functional 
significance of the upregulation of ICAM-1 (semi-static assay was used as ICAM-1 binds to its 
ligands only under static conditions).  Semi-static adhesion assays were performed by 
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introducing HL60 cells into the flow chamber (shear stress of 0.5 and 1.0 dynes/cm2), stopping 
the flow, incubating for 15 minutes allowing the HL60 cells to adhere to the endothelium, and 
reintroducing the flow at shear stress of 0.5 and 1.0 dynes/cm2. 
 
Statistical Analysis 
One way analysis of variance (ANOVA) was used to detect significant differences among 
the groups (control, irradiated and IL-1β activated control) for the upregulation of adhesion 
molecules. A two-way analysis of variance was performed to detect significant changes with 
respect to time (5, 24, 48 and 72 hr), and radiation dose (5 and 10 Gy). ANOVA was performed 
using SIGMASTAT software. A multiple comparison method (Fisher’s least significant 
difference, LSD) was used to discriminate between the means. Differences between the mean 
were considered statistically significant if P<0.05.  
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Chapter 4. RESULTS 
 
Expression of adhesion molecules following was quantified using flow cytometry at 5 hr, 
24 hr, 48 hr and 72 hr post-irradiation (10 Gy) on endothelial cells obtained from large vessels 
(HUVECs) and microvessels (HDMECs and HMEC-1). All the data for irradiated endothelial 
cells corresponds to a dose of 10 Gy unless stated otherwise. Statistically significant differences 
were observed for the expression of E-selectin only on HDMECs (control vs. irradiated). 
Statistically significant different levels of  ICAM-1 were observed on all three endothelial cell 
types: HUVECs, HMEC-1 and HDMECs post-irradiation.  The functional consequence of the 
presence of adhesion molecules was investigated using an  in vitro flow chamber at shear stress 
values of 0.5-2.0 dynes/cm2 at 5 hr, 24 hr and 48 hr post-irradiation.  Significant differences were 
found for HDMECs (control vs. irradiated) and HUVECs (control vs. irradiated).   
The data are presented as Mean ± SEM (Standard Error of the Mean), where * represents 
(P<0.05) and ** represents (P<0.01).  In order to investigate the controversial results regarding 
the upregulation of adhesion molecules depending on the radiation source (x-ray or gamma), we 
compared the expression of adhesion molecules following x-ray and gamma radiation. 
Multifactor analysis of variance (ANOVA) was used to examine the effects of the two factors 
(time and radiation type) and their interactions on the expression of the adhesion molecules. We 
did not find significant differences (P>0.05) in the upregulation of adhesion molecules based on 
the radiation source (for example, Figure 4-1 shows the expression of ICAM-1 post-irradiation 
based on the radiation source).  Hence the data from the x-ray or gamma sources were pooled 
together to increase the statistical power. 
 
 
 
 30
          Figure 4-1. Comparison of expression of ICAM-1 on HUVECs using x-ray or  
          gamma-radiation. N=6 for all groups, P>0.05 (x-ray vs. gamma) 
 
 
Morphology of Endothelial Cells Following Irradiation 
Endothelial cells started to become elongated and irregular in shape by 48 hr post-
irradiation and started to lose contact with the adjacent cells (Figure 4-2b) leaving gaps in the 
monolayer. By 72 hr post-irradiation, more endothelial cells started to peel off leaving prominent 
visible gaps in the monolayer of cells. IL-1β activated cells also became elongated by 48 hr post-
irradiation (Figure 4-2c), but maintained their contacts with adjacent endothelial cells at 48 hr 
and 72 hr post-irradiation. Control cells, however, retained their normal shape at all the time 
points and maintained uniform contact with the adjacent cells (Figure 4-2a). 
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(a) 
 
(b) 
 
(c) 
 
Figure 4-2. Morphology of endothelial cells following activation and irradiation. 
(a). Non-IR HUVECs, (b). 48 hr post-IR HUVECs, (c). 48 hr post-IL-1β activated HUVECs 
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Expression of E-selectin on Endothelial Cells 
 E-selectin expression was analyzed at 5 hr, 24hr and 48 hr post-irradiation using flow 
cytometry on HUVECs, and HMEC-1. Experiments were conducted on HDMECs only at 5 hr 
post-irradiation. 72 hr time point post-irradiation was not considered because E-selectin 
expression by endothelial cells following activation by an inflammatory substance has been 
found to peak at 4-6 hr post-activation and returning to baseline values by 48 hr (9) post-
activation.  Non-irradiated cells served as negative controls and IL-1β activated cells served as 
positive controls. 
 
Expression of E-selectin on HUVECs:   
HUVECs were used at passage 3-5 for these studies. These passage allow for uniform 
expression of the adhesion molecules by the endothelial cells. Flow cytometric analysis showed 
that HUVECs did not have a base line expression of E-selectin (Figure 4-3a). E-selectin 
upregulation was also not observed at 5 hr (Figure 4-3b), 24 hr (Figure 4-4) and 48 hr post-
irradiation (Figure 4-4).  
However, E-selectin was upregulated by IL-1β and peaked at 5hr post-activation. There 
was a significant increase in the mean fluorescence intensity (Figure 4-3c) and in the number of 
cells expressing E-selectin. Almost 60-65 % of the cells were expressing E-selectin at this time 
point (Figure 4-4) post activation. The percentage of cells expressing E-selectin and the mean 
fluorescence intensity decreased at 24 hr post-activation by IL-1β and returned to almost 
baseline levels by 48 hr post-activation.  Figure 4-4 provides a summary of the data for the 
expression of E-selectin on HUVECs.  
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(a) 
 
(b) 
 
       (c)  
 
Figure 4.3. Flow cytometry plots showing expression of E-selectin on HUVECs. 
(a). Non-IR (Control), (b). 5 hr post-IR (10 Gy), (c). 5 hr post-IL-1β activated 
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                   Figure 4-4. Expression of E-selectin post-IR (10 Gy) on HUVECs. 
                   N=3 for all groups, Mean± SEM, P<0.01 (for IL-1 beta vs. control) 
 
 
Expression of E-selectin on HMEC-1:  
HMEC-1 used in this study were passaged from 22-26. HMEC-1 did not possess a basal 
level of E-selectin expression. E-selectin expression was not upregulated by ionizing radiation 
(Figure 4-5). Interestingly, IL-1β failed to induce the expression of E-selectin in HMEC-1 
(Figure 4-5).  
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                   Figure 4-5. Expression of E-selectin post-IR (10 Gy) on HMEC-1.  
                   N=3 for all groups, Mean ± SEM, P >0.05  
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Expression of E-selectin on HDMEC: 
        HDMEC cells used for this study were at passage 3-6. Surprisingly, flow cytometric 
analysis indicated that HDMECs have a basal level of E-selectin expression (Figure 4-6). 
Approximately 7 % of the cells were expressing E-selectin under control conditions. E-selectin 
was upregulated 5 hr post-irradiation on HDMECs (Figure 4-6).  
 
 
 
      Figure 4-6. Expression of E-selectin on 5hr post-IR (10 Gy) HDMECs.   
                  N=3, Mean± SEM, P <0.05(for control vs. IR), P<0.01 (IL-1 beta vs. control) 
 
 
Expression of ICAM-1 on Endothelial Cells 
ICAM-1 expression was quantified at 5 hr, 24 hr, 48hr and 72 hr post-irradiation. 
 
Expression of ICAM-1 on HUVECs:  
A flow cytometric plot of control HUVECs at 72 hr is shown in Figure 4-7a.  10-15% of 
the HUVECs had a basal level of ICAM-1, which increased to 25-30% by 72 hr in non-irradiated 
controls. ICAM-1 was upregulated at 48 hr post-irradiation and the level increased by 72 hr 
(Figure 4-7b). IL-1β activated cells increased the expression of ICAM-1 by 5 hr, reaching a 
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maximum level by 24 hr which remained elevated at 72 hr post-activation (see Figure 4-7c). The 
data is summarized in Figure 4-8. 
 
(a)         
 
          (b) 
 
(c). 
Figure 4-7. Flow cytometry plots showing expression of ICAM-1 on HUVECs. 
(a). Non-IR (Control), (b). 72 hr post-IR (10 Gy), (c). 72 hr post-IL-1β activated. 
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Figure 4-8. Expression of ICAM-1 on post-IR (10 Gy) HUVECs. 
 N=5 for all groups,  Mean ± SEM, P <0.05 (control vs. IR or IL-1 beta) 
 and P<0.01(control vs. IR or IL-1 beta) 
 
 
Expression of ICAM-1 on HMEC-1: 
HMEC-1 were used at passages 21-26 for these series of experiments. HMEC-1 had a 
basal level of ICAM-1 expression similar to that observed on HUVECs (10-12% of the cells 
expressed ICAM-1).  ICAM-1 was upregulated at 48 hr post-irradiation and the level increased 
significantly by 72 hr post-irradiation (Figure 4-9). However, the level of ICAM-1 upregulation 
was only 1.5 times (control vs. irradiated)  which was significantly less compared to the ICAM-1 
level on HUVECs (2.4 fold increase on irradiated HUVECs compared to control). In addition, 
IL-1β activated cells expression of ICAM-1 was also significantly less (75 % of the cells 
expressed ICAM-1) than the corresponding levels of expression of ICAM-1 by HUVECs  (90% 
of the cells were expressing ICAM-1). 
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              Figure 4-9. Expression of ICAM-1 on post-IR (10 Gy) HMEC-1.  
              N = 3 for all groups, Mean ±  SEM, P<0.05 (control vs. IR or IL-1 beta),  
              P<0.01 (control vs. IR or IL-1 beta) 
 
 
Expression of ICAM-1 on HDMECs: 
       HDMECs had a significantly higher basal level of ICAM-1 compared to HMEC-1 
and HUVECs. Almost 50-55% of the cells expressed ICAM-1 (Figure 4-10).  However, ICAM-1 
was upregulated as early as 24 hr post-irradiation and the level reached 90-95% by 48 h (Figure 
4-10). 72 hr time point was not included for these cells. On IL-1β activated cells, ICAM-1 
expression peaked by 24 hr reaching 95% expression levels and remained at the same elevated 
level at 48hr post-irradiation (Figure 4-10).  
A summary of data representing the time and significant level of upregulation of 
adhesion molecules; E-selectin and ICAM-1 on the endothelial cells is presented in Table 4-1. 
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Figure 4-10. Expression of ICAM-1 on post-IR (10 Gy) HDMECs. 
                    N=3 for all groups, P<0.01(control vs. IR or IL-1 beta) 
 
 
 
 
Table 4-1. Summary of the adhesion molecules being upregulated following irradiation. 
Time Post-Irradiation (10 Gy) . Cell type 
 
Molecules  Baseline 
Expression 
5 hr           24 hr         48 hr           72 hr 
E-selectin 
 
No No No No No  
HUVECs 
 ICAM-1 Yes No No Yes 
( P<0.01) 
Yes 
 ( P<0.01) 
E-selectin 
 
No No No No No  
HMEC-1 
 ICAM-1 Yes No No Yes 
( P<0.05) 
Yes 
(P<0.01) 
E-selectin Yes Yes 
( P<0.05) 
NA NA NA  
HDMECs 
 ICAM-1 Yes No Yes 
(P<0.01) 
Yes 
(P<0.01) 
NA 
 
 
** 
   ** 
 ** 
 
    ** 
  ** 
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In Vitro Flow Chamber Assay 
Flow chamber results corroborated the flow cytometry data and gave a functional tool to 
study the importance of these molecules on the interaction between the endothelial cells and the 
leukocytes. In order to verify the presence of the ligands of E-Selectin and ICAM-1 on HL60 
cells, flow cytometry was utilized. 
 
Flow cytometry on HL60 cells:  
HL60 cells were found to possess the E-selectin ligand; SLex and PSGL-1 (Figure 4-11) 
and the corresponding ligand for ICAM-1; LFA-1 and the β2 chain of the integrins (Figure 4-12). 
Mac-1 was not observed on HL60 cells (Figure 4-12).  
 
(a) 
 
(b) 
Figure 4-11. Flow cytometry plots for the expression of ligand of E-selectin on HL60 cells. 
                                           (a). PSGL-1 expression, (b). SLex expression 
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(a).  
 
 
(b) 
 
           (c) 
Figure 4-12. Flow cytometry plot for the expression of ligands of ICAM-1 on HL60 cells. 
              (a). β2 expression, (b). LFA-1 expression, (c). Mac-1 expression. 
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For the flow assays, HL60 cells were perfused over endothelial cells (Non-Irradiated, 
Irradiated and IL-1β activated) at shear stress values of 0.5-2.0 dynes/cm2 in an in vitro parallel 
plate flow chamber and the number of rolling and adherent HL60 cells were quantified off line as 
indicated in methods section. 
 
Interaction of HL60 cells with HUVECs under conditions of flow: 
HL60 cells did not roll on 5 hr control and post-irradiated HUVECs (Table 4.2).  
However, HL60 cells rolled and adhered at 5 hr post-IL1β activated cells and the number varied 
inversely with shear stress (Table 4-2 and Figure 4-13). This observation corroborated the 
absence of E-selectin upregulation post-irradiation. HL60 cells also did not roll and adhere at 24 
hr post-irradiated HUVECs. The number of HL60 cells rolling and adhering at 24hr post-IL1β 
activated cells also decreased.   
 
 
Table 4-2. Number of rolling and adherent HL60 cells on 5 hr post-IR (10 Gy) HUVECs 
Shear Stress 
(dynes/cm2) 
Control 
 
 
Number Of Cells  
Irradiated  (10 Gy) 
 
 
Number Of Cells  
IL-1β Activated 
HUVECs 
 
Number Of Cells 
 Rolling Adhering Rolling Adhering Rolling Adhering 
0.5 0 0 0 0 85.2±2.0 80.0±3.2 
1.0 0 0 0 0 70.0±1.5 61.0±4.3 
1.5 0 0 0 0 42.3±1.7 37.0±3.0 
2.0 0 0 0 0 34.7±0.8 17.3±2.0 
Notes: N= 5, Mean ±SEM, P<0.01 for differences between control and IL-1β. 
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Figure 4-13. HL 60 cells rolling and adhering on 5 hr post-IL-1β HUVECs. 
N=5, Mean ±SEM 
 
 
              Semi-static flow assay at 48 hr post-irradiation performed by introducing HL60 cells 
into the flow chamber, stopping the flow, incubating for 15 minutes, and reintroducing the flow 
at shear stress of 0.5 and 1.0 dynes/cm2 revealed an increase in the number of adherent cells 
compared to controls (Table 4-3). At shear stress of higher than 1.0 dynes/cm2, the endothelial 
cell started to dissociate from the tissue culture dishes. IL-1β activated cells showed a 
significantly higher statistical difference for the number of adherent cells. The adherent cells 
varied inversely with the shear stress as before. At 72 hr post-irradiation, endothelial cells started 
to peel of as the flow was introduced. Hence, the number of rolling or adherent HL60 cells could 
not be quantified at this time point. 
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Table 4-3. Number of adherent HL60 cells on 48 hr post-IR (10 Gy) HUVECs. 
Shear Stress 
(dynes/cm2) 
Control 
 
 Number Of Cells 
Irradiated (10 Gy)  
 
Number Of Cells  
IL-1β Activated 
HUVECs 
Number Of Cells  
0.5 5.3±0.8 16.3±1.7 26.4±1.7 
1.0 4.3±0.8 11.7±0.7 22.4±1.7 
Notes: Mean ± SEM, N = 4, P<0.01 for differences between control and irradiated. 
 
 
Interaction of HL60 cells with HMEC-1 under conditions of flow: 
Only 5hr post-irradiation flow assay was performed on HMEC-1.  HL60 cells did not roll 
or adhere on 5 hr post-activated cells. Consistent with the absence of E-selectin on HMEC-1 as 
observed by flow cytometry, HL60 cells failed to roll and adhere on IL-1β activated HMEC-1 
(data not shown). 
 
Interaction of HL60 cells with HDMECs under conditions of flow:  
5hr post-irradiation flow assay on HDMECs revealed an increase in the number of rolling 
(Figure 4-14) and adherent cells (Figure 4-15) and the number varied inversely with shear stress. 
On control HDMECs also, there was a significant amount of rolling and adhering of HL60 cells, 
which was evident at shear stress of 1.5 dynes/cm2. The number of rolling and adherent HL60 
cells increased as the shear stress was reduced to 1.0 and 0.5 dynes/cm2. However, at 2.0 
dynes/cm2, there was no significant difference (P>0.05) between the irradiated and control 
groups. IL-1β activated HDMECs showed the maximum number of HL60 cells rolling and 
adhering (Figure 4-14, 4-15). The data is summarized in table 4-4. 
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Figure 4-14. HL60 cells rolling on 5 hr post-IR (10 Gy) HDMECs. N=3, Mean ± SEM,      
           P <0.05 (control vs. IR or IL-1 beta), P<0.01 (control vs. IR or IL-1 beta) 
 
 
        Figure 4-15. HL60 cells adhering on 5 hr post-IR (10 Gy) HDMECs. N=3, Mean ± SEM,  
                      P <0.05 (control vs. IR or IL-1 beta), P<0.01 (control vs. IR or IL-1 beta) 
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Table 4-4. HL60 cells rolling and adhering on 5 hr post-IR (10 Gy) HDMECs. 
Shear Stress 
(dynes/cm2) 
Control 
Number Of Cells 
Irradiated  (10 Gy) 
Number Of Cells 
IL-1β Activated 
Number Of Cells 
 Rolling Adhering Rolling Adhering Rolling Adhering 
2.0 13.4±0.8 12.3±0.8 17.7±0.7 15.7±0.8 55.7±1.7 48.0±1.7 
1.5 22.67±1.4 18.6±0.8 29.7±1.7 34.7±4.2 68.7±3.2 102.3±2.8 
1.0 31.0±1.7 44.3±1.8 48±3.6 77±2.8 82.0±1.7 164.0±3.4 
0.5 36±3.0 53.0±1.5 61.4±1.4 105.6±2.4 100±5.1 215.7±4.6 
           Notes: Mean ± SEM, P<0.05 and P <0.01 for differences between Control and Irradiated. 
 
 
Comparison of Different Doses 
In order to investigate the dose dependence on the expression of adhesion molecules, 
studies were conducted on HUVECs at 48 hr and 72 hr post-irradiation (5 Gy) to compare the 
expression of ICAM-1. There was a no significant difference (P >0.05) at 48 hr post-IR between 
the two groups (5 Gy vs. 10 Gy). However, at 72 hr post-IR, a statistically significant difference 
(P<0.05) was observed on the expression of ICAM-1 (Figure 4-16). 
 
Figure 4-16. Effect of dose on the expression of ICAM-1 post-IR on HUVECs. 
                                           N=3, Mean  SEM, P<0.05 (5 Gy vs. 10 Gy) 
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Chapter 5. DISCUSSION 
Normal tissue damage is a side effect of radiation therapy.  The effects of radiation  were 
studied on endothelial cells derived from a large vessel (HUVEC) and a small vessel (HDMEC) 
and the transformed dermal microvascular endothelial cell line (HMEC-1).  Expression  of 
adhesion molecules was quantified by flow cytometry. The functional significance of the 
upregulation of the adhesion molecules was investigated in an in vitro flow chamber using shear 
stress values comparable to those observed in the post-capillary venules. 
   Our findings suggest that ionizing radiation selectively impacts the functional aspects of 
the inflammatory response. Endothelial cells were found to have differences in the basal level  
expression of adhesion molecules based on their origin; the most surprising finding was the fact 
that HDMECs possessed a basal level of E-selectin). Endothelial cells differed in the 
upregulation of adhesion molecules in a time and radiation dose dependent manner. The mode of 
radiation (x-ray vs. gamma) did not cause significant changes (P>0.05) in the upregulation of 
adhesion molecules. HL60 cells rolled and adhered on the endothelial cells depending on the 
presence of adhesion molecules: E-selectin and ICAM-1. 
 
Comparison of Control Data with Literature 
There has been many studies to quantify the expression of adhesion molecules following 
activation with IL-1, TNF-α and LPS (9,10,11,62,72). A few studies (16,27,51,50,52) have also 
investigated the effects of these adhesion molecules on the interaction of the leukocytes to the 
activated endothelium under flow following activation with IL-1. Our results regarding the 
upregulation of adhesion molecules  (basal level and upregulation with IL-1β) are in good 
agreement with the previously published results using IL-1 or TNF-α as the inflammatory agent 
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(74,73). Although, in our studies we used 10 U/ml of IL-1β, and other investigators have used 
upto 500 U/ml, our results agree with the time course of the upregulation of the molecules also.   
All the endothelial cells had a basal level of ICAM-1 consistent with previously 
published results (31,42). The only interesting deviation from the data in the literature is the 
finding that HDMEC cells possess a basal level of E-selectin. According to the available 
literature, this is the first time that HDMECs or any endothelial cells has been found to have a 
basal level of E-selectin expression. This surprising feature could be due to differences in the 
processing of cells that could have turned on the E-selectin gene to produce the molecule. There 
is a second possibility that HDMECs do have a basal level of E-selectin, which so far no one has 
observed. The HDMECs used  in our study were obtained from neonatal foreskins. Previously 
published data on HDMECs obtained from the mammary skins (47), pulmonary microvascular 
endothelial cells (32) and from the neonatal foreskins  did not show any basal level of E-selectin 
(20,75). However, In vivo, investigators have seen a basal level of E-selectin (67).  
 
Effects of Ionizing Radiation 
In the last 5 years, there has been several investigations of the expression of adhesion 
molecules following radiation (36,37,39,38,41,40, 42,31,30). However, there has been 
inconsistent data in the literature regarding the upregulation of the adhesion molecules.  In 
addition, although static adhesion studies have been performed, no study has looked into the 
adhesion of leukocytes in a dynamic situation under conditions of flow. This study is the first to 
use a dynamic flow system to study the interaction of the HL60 cells to endothelial cells 
following ionizing radiation in order to investigate the functional significance of the presence of 
adhesion molecules on the endothelium following ionizing radiation.  
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The endothelial cell morphology changed following irradiation. Cells started to became 
more elongated and irregular in shape by 48 hr post-irradiation and by 72 hr almost all the cells 
assumed the irregular shape. At 72 hr, a fraction of the endothelial cells started to peel off from 
the culture dishes leaving gaps in the confluent monolayers. However, the control (non-irradiated 
cells) remained firmly adhered. This is in agreement with other findings that endothelial cells 
tend to change their morphology by becoming more irregular in shape following irradiation (5). 
Loss of endothelial cells from vessels in vivo following radiation has also been reported (5).  
All the endothelial cells exhibited different type of expression of adhesion molecules 
following ionizing radiation.  E-selectin was significantly upregulated at 5hr post-irradiation by 
HDMECs. The level of expression of E-selectin on irradiated HDMECs (17%) had 
approximately a 2.5 fold increase compared to that of controls (7%).  
There has been only one previous study on the expression of E-selectin following 
ionizing radiation (42) on HDMECs. Their results show that E-selectin mRNA was strongly 
induced at 24 hr post-irradiation. However, they did not investigate the cell surface expression of 
E-selectin following ionizing radiation. The same group of investigators showed E-selectin 
expression at the cell surface was upregulated 6 hr post-UV radiation (43). Although, we do not 
know how much correlation is there between UV and ionizing radiation mediated activation, our 
data is in good agreement regarding the time point of  upregulation of E-selectin.  
HUVECs did not express E-selectin following ionizing radiation. Previously published 
works in the literature suggest both presence (35,36,37,41) as reported by Hallahan et al. and 
absence of E-selectin following ionizing radiation as reported by Gaugler et al (31). The 
rationale for the difference between their findings was based on the radiation source (x-ray vs. 
gamma). However, our study showed that the radiation source did not cause significant 
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differences in the upregulation of adhesion molecules (P>0.05). Our data agrees with the 
published work (31) that E-selectin is not upregulated on HUVECs following ionizing radiation 
exposure. 
HMEC-1 also did not express E-selectin following ionizing radiation. This is in 
agreement with previously published results using UV radiation (67). Interestingly, even after 
activation with IL-1β, E-selectin was not upregulated. HMEC-1 is the immortalized transformed 
progeny of HDMECs. These data suggest that the immortalized transformed cell probably lose 
their ability to express some adhesion molecules.  
We used HL60 cells as  a substitute for leukocytes to study the functional interactions 
with the endothelium. HL60 cells possess the primary counter ligands of E-selectin and ICAM-1, 
namely PSGL-1, Slex, β2 integrins and LFA-1 that are present on the leukocytes. HL60 cells did 
not roll or adhere on 5hr and 24 hr post-irradiated HUVECs and HMEC-1 confirming the 
absence of E-selectin. Hallahan et al. have performed static assays (incubating the irradiated, at 5 
hr post-IR HUVECs with HL60 cells) and observed a significant increase in adherent HL60 cells 
(36).  Our results do not agree with their data. ICAM-1 is needed for firm arrest of HL60 cells on 
the endothelial cells. Since in their studies also they observed ICAM-1 expression only at 16 hrs 
post-IR, it is difficult to visualize their results. We performed a semi-static flow assay on 5 hr 
post-IR HUVECs by starting the flow, allowing the HL60 cells to interact with the  endothelial 
cells, incubating the HL60 cells for 5 minutes and restarting the flow. Our results did not show 
any adherent HL60 cells. However, HL60 cells did roll and adhere on IL-1β activated HUVECs. 
These data suggest that E-selectin is not upregulated by ionizing radiation on HUVECs (in 
agreement with  Gaugler et al.) and HMEC-1 (in contrast to Hallahan et al.)  
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Flow assays on 5 hr  post-IR HDMECs revealed an increase in the number of rolling and 
adhering cells and the number varied inversely with shear stress. However, significant 
differences (P<0.05) were observed only at shear stress of 1.5 dynes/cm2 or less. At 2.0 dynes/ 
cm2, there was no significant difference (P>0.05) between control and irradiated HDMECs. 
There was a significant amount of rolling on non-activated HDMECs corroborating our findings 
of small amount of basal E-selectin being present in a persistent manner. IL-1 β activated 
HDMECs showed the maximum number of rolling and adherent leukocytes. 
ICAM-1 was upregulated on all the three-endothelial cell types. On HUVECs, ICAM-1 
was upregulated 48 hr post-irradiation. This observation is again in contrast and agreement with 
published data. Our findings does not agree with the observations of Hallahan et al. that ICAM-1 
is upregulated as early as 16 hrs post-irradiation on HUVECs (36). However, we observed the 
upregulation of ICAM-1 at the same time point as observed by Gaugler et al. (31). 
In HMEC-1 also, ICAM-1 was upregulated at 48 hr post-irradiation. This is also in 
contrast to the previously published results where ICAM-1 was upregulated by 24 hr post-
irradiation using UV radiation (67). 
However, on HDMECs, ICAM-1 was upregulated as early as 24 hr post-irradiation. This 
is in agreement with the ICAM-1 mRNA levels upregulation observed in previous studies (42). 
Our findings, however is the first study to report the cell surface expression of ICAM-1 on 
HDMECs following radiation. 
On 48 hr post-IR HUVECs, following a semi-static assay, there was a significant amount 
(P<0.05) of HL60 cells adhering to the irradiated HUVECs compared to control.  There is data in 
the literature by Hallahan et al. showing increased adhesion of HL60 cells to HUVECs  24 hr 
post-IR (36). However, our experimental time point is different from their studies (48 hr vs. 24 
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hr post-IR). Static assays need ICAM-1 to mediate firm adhesion. Since in our studies ICAM-1 
was upregulated only at 48 hr post-IR, we used the 48 hr time point. 
The increase in the number of HL60 cells rolling and adhering on irradiated HDMECS 
but not on HUVECs  and the selective upregulation of adhesion molecules on endothelial cells  
suggest that the response of radiation damage on  endothelial cells from different parts of the 
body will differ. Our findings are consistent with previous studies showing that endothelial cells 
of the body differ from each other based on their origin.   
Based on our studies, HDMECs are probably the most sensitive to radiation damage, or 
in other words, microvasculature of the body is most sensitive to radiation damage. Since 
HUVECs are from large vessels and HDMECs from small vessels, it may be justifiable to 
suggest that microvessels may be the primary site of increased leukocyte-endothelial interaction 
leading to tissue damage following radiation.  It has also been shown previously that the E-
selectin expression persists at a higher level on HDMECs compared to HUVECs at 24 hr post-
activation (47).  This could probably help the leukocytes to mediate tissue damage for longer 
duration of time. 
During radiation therapy, patients are treated with fractionated doses over a period. In 
order to investigate the effect of radiation dose on the expression of adhesion molecules, we used 
the 48 hr and 72 hr post-IR time points on HUVECs expression of ICAM-1 for this comparative 
study.  Although, there was no significant difference (P>0.05) at 48 hr post-irradiation  between 
the two groups (5 Gy or 10 Gy), there was a significantly higher amount of difference at 72 hr 
post-irradiation (P<0.01). It could be due to the fact, that the onset of radiation damage may have 
the same latent period irrespective of the amount of radiation damage. However, once the 
expression of the molecule begins, there may be a dose dependent urgency to speed up the 
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expression  of ICAM-1. Published data shows that at 4 days post-irradiation, the ICAM-1 levels 
of both 5 Gy and 10 Gy irradiated HUVECs were almost at the same level (31).  This could be 
due to the fact that, the adhesion molecules plateau off at certain limits. Adhesion molecules may 
reach the limit at different time points depending upon the dose of radiation.  
In brief, our study suggests a difference in the radiation damage of endothelial cells 
depending upon their origin. The adhesion molecules play a significant role in the tissue damage 
following radiotherapy. There is a dose dependent increase of adhesion molecules, which may 
plateau off.  The mechanism of this damage is probably similar to the one following an 
inflammatory response in the body. Leukocytes migrate to the site of injury, roll and adhere via 
adhesion molecules, extravasate into the tissues and  mediate damage. 
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Chapter 6. CONCLUSION 
This study investigated the expression of adhesion molecules on the endothelium 
following ionizing radiation. The functional significance of the upregulation of these adhesion 
molecules, and the dose dependence on the upregulation of the adhesion molecules was also 
investigated. These results could lead to a better understanding  of the side effects of radiation 
therapy and may aid in minimizing these side effects.  
 
Our results indicate that: 
1. There is a difference in the response of endothelial cells to radiation damage based on their 
origin. 
2. There is no difference in the upregulation of adhesion molecules on endothelial cells in 
response to x-ray or gamma irradiation. 
3. E-selectin is upregulated by ionizing radiation on HDMECs at 5 hr post-irradiation. 
HDMECs possess a basal level of E-selectin. 
4. ICAM-1 is upregulated on HDMECs at 24 hr post-irradiation and increases its expression 
by 48 hr. 
5. ICAM-1 is upregulated on HUVECs and HMEC-1 at 48 hr post-irradiation and increases 
by 72 hr. 
6. Transformed HDMECs (HMEC-1) do not express E-selectin under control conditions 
7. HL 60 cells rolled and adhered on 5 hr post-irradiated HDMECs in significantly larger 
number than on control HDMECs. 
8. HL60 cells adhered in significantly larger numbers on 48 hr post-irradiated HUVECs 
following a semi-static assay. 
 55
These data suggest that endothelial cells probably respond to radiation damage in the 
same manner following a inflammatory response, which is initiated by the upregulation of 
adhesion molecules. Leukocytes then roll and adhere to the endothelium via these adhesion 
molecules, extravasate into the tissues and cause damage.  
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Chapter 7. FUTURE WORK 
 
1. Study the effect of antibodies in blocking the upregulation of adhesion molecules 
following irradiation. 
2.  Investigate the use of radioprotective agents to prevent the upregulation of adhesion 
molecules. 
3. Corroborate these in vitro findings with  in vivo studies. 
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Steps in Running an In Vitro Flow Chamber Assay 
 
 
1. Warm the buffer/media to 37°C 1 hr. prior to beginning flow assay. 
 
2. Assemble flow system apparatus connecting inlet, outlet, and vacuum lines to the flow   
      chamber deck with the help of 3-way stopcock connected to two 10 ml syringes.  
 
3. Apply a small amount of vacuum grease on the gasket and attach to the flow chamber. 
Make sure no grease was present on the side coming in contact with the cells. Smoothen 
the gasket so it is free from any wrinkles and leave the system undisturbed for at least one 
hour prior to use.      
 
4. Fill the system with media and remove all air from system. 
 
5. Fill inlet reservoir (usually a 10 ml disposable syringe) with cell suspension. The cell 
concentration should be 105 or 106 cells/ml   
 
6. Attach an empty 35mm dish to flow chamber deck. Hold the deck inverted, place a small 
bubble of media on flow path area, then  place the 35 mm dish on the deck. Switch on the 
vacuum. Vacuum will hold dish on deck. Make sure dish was attached with no air 
bubbles in the chamber. 
 
7. Place assembled chamber on microscope stage. 
 
8. Initiate flow of buffer/media with the syringe pump with shear stress of 0.5-1.0 
dynes/cm2 till there is no air bubble in the path.  
 
9. Remove the dish and replace it with dish containing monolayer of cells. Initiate flow of 
cells syringe pump connected to outlet flow chamber at a shear stress in the range of 0.5-
2.0 dynes/cm2. 
 
10. Allow cells to flow for sufficient time (3- 5 minutes) to get an adequate number of cells  
       interacting with the cell monolayer. 
 
11. Begin image acquisition. Collect images at 8-10 locations on the dish. Generally 3 dishes     
      at a given experimental condition gives enough data to show statistical differences       
      between treatments.  
 
12. After images are acquired on all dishes, perform image analysis to quantify the flow   
         assay using Metamorph Imaging Software. 
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